Searched for
NEPHROCARE EXPANSION
Nephrocare Health shares list at 7% premium over IPO priceNephrocare Health Services debuted on stock exchanges with a 7% premium, opening at Rs 491.70 on BSE and Rs 490 on NSE. The company's Rs 87...- Park Medi World shares list at 4% discount to IPO price on exchangesPark Medi World debuted on the stock market, listing at a discount of up to 4% despite strong IPO demand. The IPO saw an overall subscripti...
- Why are so many Indian hospitals rushing to the market?India's healthcare sector is poised for a significant IPO boom in 2026, with hospitals and allied services expected to raise Rs 20,000 cror...
- Nephrocare Health IPO Day 3: GMP slips to 2% and subscription remains subdued — Should you apply?Nephrocare Health IPO: The stock’s grey-market premium has slipped to 1.7% from 4.35%, indicating softer sentiment and a likely listing ran...
- Nephrocare Health IPO Day 2: GMP improves but subscription demand remains weak. Should you apply?Nephrocare Health Services’ Rs 871-crore IPO has seen a muted initial response despite an improving grey market premium. Strong financial g...
- Nephrocare Health IPO Day 1: Issue subscribed 7%; no GMP. Should investors apply?Nephrocare Health IPO consists of a ₹353-crore fresh issue and a ₹518-crore offer for sale. Of the fresh issue funds, Nephrocare Health Ser...
- Nephrocare Health IPO: Check GMP, review, subscription and other detailsNephrocare Health Services, India's largest dialysis provider, launched its Rs 871 crore IPO on Wednesday, offering a stake in its rapidly ...
- NephroPlus announces IPO launch on December 10. Check key detailsNephrocare Health Services’ IPO opens December 10 with a fresh issue and OFS totaling significant funds. Proceeds will support new dialysis...
- IPO pipeline swells; 2 dozen companies line up Rs 40,000-cr public offers in Dec-JanAccording to him, India's robust consumption story, aided by GST and income-tax rationalisation, has encouraged many consumer-facing busine...
- NephroPlus gets Sebi nod to launch IPO, to raise Rs 353 crore from fresh issueDialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising...
- Dialysis chain NephroPlus eyes Rs 2,000 crore IPONephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 cr...
- Tata Capital sells stake in Indian dialysis service provider to Fresenius Medical CareFMC’s acquisition of Sandor marks the beginning of a series of investments the company intends for its expansion in the Indian dialysis mar...
- Fresenius acquires 85 per cent stake in Sandor Nephro ServicesEstablished in 2011, Sandor Nephro Services operates around 55 dialysis centres while Fresenius Medical Care runs three such centres across...
Load More
